Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06449638 · ClinicalTrials.gov registry record · NA

Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs

A NA study of Diabetic Foot and Diabetic Foot Ulcer (DFU), sponsored by StimLabs.

Recruiting
Registry status
NA
Development phase
272
Enrollment target
5
Study locations

NCT06449638 is a NA study of Diabetic Foot and Diabetic Foot Ulcer (DFU) that is actively recruiting participants, run by StimLabs. The registered enrollment target is 272 participants, below the 10,332-participant average among 30 other Diabetic Foot trials with a reported enrollment target (97% lower). The trial reports 5 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06449638, a NA study of Diabetic Foot and Diabetic Foot Ulcer (DFU), is actively recruiting participants, sponsored by StimLabs.

RECRUITING
Registry status
NA
Development phase
272 participants
Enrollment target
5
Study locations

Study Summary

The purpose of this study is to evaluate the efficacy of four dehydrated complete human placental membrane, also defined as Cellular, Acellular, Matrix-like Products/skin substitutes, plus SOC versus SOC alone in achieving complete closure of hard-to-heal diabetic foot ulcers over 12 weeks using a modified platform trial design.

Interventions

  • OTHER Standard of Care
  • OTHER Revita
  • OTHER Relese
  • OTHER Cogenex
  • OTHER Enverse

Study Locations (5)

Pennsylvania

  • SerenaGroup Research South - Jefferson Hills
  • Armstrong County Memorial Hospital - Kittanning
  • SerenaGroup Monroeville - Monroeville

Nebraska

  • SerenaGroup Omaha Research Center - Omaha

Oklahoma

  • Wound Care of Tulsa - Tulsa

Trial Details

FieldValue
Enrollment Target 272 participants
Start Date 2024-07-16
Est. Completion 2026-12
Phase NA

Sponsor

StimLabs

5 total trials

What the Registry Record Tells You About NCT06449638

The ClinicalTrials.gov registry entry for NCT06449638 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 272 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 10,332-participant average among 30 other Diabetic Foot trials with a reported enrollment target (97% lower). The listed sponsor is StimLabs, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Diabetic Foot appearing as the primary indexed condition, and to 5 interventions - of which Standard of Care is the first listed.

NCT06449638 reports 5 study locations spanning 3 distinct geographic areas - top geographies include Pennsylvania, Nebraska, Oklahoma.

Frequently Asked Questions

What is clinical trial NCT06449638 about?

NCT06449638 is a clinical study titled "Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs". The purpose of this study is to evaluate the efficacy of four dehydrated complete human placental membrane, also defined as Cellular, Acellular, Matrix-like Products/skin substitutes, plus SOC versus SOC alone in achieving complete closure of hard-to-heal diabetic foot ulcers over 12 weeks using a m...

What is the current status of trial NCT06449638?

This trial is currently recruiting. It is a NA study. The enrollment target is 272 participants. The study started on 2024-07-16. Estimated completion is 2026-12.

What conditions does trial NCT06449638 study?

This clinical trial studies the following conditions: Diabetic Foot, Diabetic Foot Ulcer (DFU), Foot Ulcer, Ulcer Foot.

What interventions are being tested in trial NCT06449638?

The interventions under investigation include: Standard of Care (OTHER), Revita (OTHER), Relese (OTHER), Cogenex (OTHER), Enverse (OTHER).

Who is sponsoring clinical trial NCT06449638?

This trial is sponsored by StimLabs, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06449638 being conducted?

This trial has 5 study locations across Nebraska, Oklahoma, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetic Foot

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.